Noninvasive brain modulation using sound waves shows promise for depression and anxiety

Patients suffering from depression, anxiety and trauma-related disorders experienced significant relief from their symptoms after a new treatment that uses sound waves to modulate deep brain activity, according to new research from Dell Medical School at The University of Texas at Austin. The study, published this month in Molecular Psychiatry, demonstrates that low-intensity focused ultrasound technology can safely and effectively target the amygdala - a brain region known to be hyperactive in mood and anxiety disorders - without surgery or invasive procedures.

Participants showed marked improvements across a range of symptoms after just three weeks of daily treatments. What makes this approach revolutionary is that it's the first time we've been able to directly modulate deep brain activity without invasive procedures or medications."

Gregory Fonzo, Ph.D., senior author of the study and assistant professor, Department of Psychiatry & Behavioral Sciences at Dell Med

In the double-blind study, 29 patients with various mood and anxiety disorders received MRI-guided focused ultrasound to the left amygdala. The results showed both immediate reductions in amygdala activity, and after three weeks of daily sessions, patients experienced clinically significant improvements in negative affect and symptoms of depression, anxiety and PTSD.

"For decades, the amygdala has been a target of interest, but access has required either brain surgery or indirect approaches through cortical stimulation," said Fonzo. "This technology opens a new frontier in psychiatric treatment, potentially offering relief to patients who haven't responded to traditional therapies."

The treatment was well tolerated with no serious adverse events, suggesting a promising safety profile as researchers move toward larger clinical trials.

Source:
Journal reference:

Barksdale, B. R., et al. (2025). Low-intensity transcranial focused ultrasound amygdala neuromodulation: a double-blind sham-controlled target engagement study and unblinded single-arm clinical trial. Molecular Psychiatry. doi.org/10.1038/s41380-025-03033-w.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unlocking the secrets of synaptic plasticity during learning